Modern Technologies for Synthesizing Drug Substances: Toward Highly Efficient Drug Production


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription Access

Abstract

Implementation of new technologies for synthesizing drug substances, e.g., continuous-flow microreactor synthesis of active drug substances (ADS) and asymmetric synthesis of intermediates and ADS using enzymes created by gene engineering methods, is highly significant for localizing ADS production in Russia. The possibility of using the existing Russian scientific infrastructure for rapid implementation of domestic production of a new ADS portfolio with the least operating losses, maximum economic efficiency, and high competitiveness was demonstrated.

About the authors

I. A. Narkevich

St. Petersburg State Chemico-Pharmaceutical Academy, Russian Ministry of Health

Author for correspondence.
Email: igor.narkevich@pharminnotech.com
Russian Federation, 14 Prof. Popova St., St. Petersburg, 197022

I. N. Tarasov

MicroSpin MRT GmbH

Email: igor.narkevich@pharminnotech.com
Germany, 21 Zaarland St., Wolfach, 77709

Z. M. Golant

St. Petersburg State Chemico-Pharmaceutical Academy, Russian Ministry of Health

Email: igor.narkevich@pharminnotech.com
Russian Federation, 14 Prof. Popova St., St. Petersburg, 197022

A. V. Alekhin

RF Ministry of Industry and Trade

Email: igor.narkevich@pharminnotech.com
Russian Federation, 7 Kitaigorodskii Proezd, Moscow, 109074


Copyright (c) 2016 Springer Science+Business Media New York

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies